**Core Concept**
Prokinetics are drugs that enhance gastrointestinal motility. They are crucial in treating conditions like gastroparesis, constipation, and gastrointestinal dysmotility. Prokinetics can be categorized based on their mechanism of action, which includes dopamine antagonism, serotonin receptor agonism, and acetylcholine release enhancement.

**Why the Correct Answer is Right**
Diphenoxymethane (Option D) is an anticholinergic agent that inhibits acetylcholine release, leading to decreased gastrointestinal motility. This is contrary to the action of prokinetics, which aim to increase gastrointestinal motility. Diphenoxymethane is used to treat conditions like diarrhea, irritable bowel syndrome, and diverticulitis, but it is not considered a prokinetic due to its opposing mechanism of action.

**Why Each Wrong Option is Incorrect**
**Option A:** 5HT4 agonists, such as mosapride and prucalopride, are prokinetics that enhance gastrointestinal motility by activating serotonin 5HT4 receptors, leading to increased acetylcholine release and smooth muscle contraction.
**Option B:** D2 blockers, such as metoclopramide, are prokinetics that inhibit dopamine receptors in the gastrointestinal tract, leading to increased acetylcholine release and enhanced motility.
**Option C:** Although macrolides have various effects on the gastrointestinal tract, they are not typically classified as prokinetics. However, some macrolides may have a mild prokinetic effect due to their ability to enhance gastrointestinal motility.

**Clinical Pearl / High-Yield Fact**
When treating gastrointestinal motility disorders, it is essential to differentiate between prokinetics and anticholinergics. Prokinetics like metoclopramide and mosapride can be used to treat conditions like gastroparesis and irritable bowel syndrome, while anticholinergics like diphenoxymethane are used to treat conditions like diarrhea and diverticulitis.

**✓ Correct Answer: D. Diphenoxymethane**